159 related articles for article (PubMed ID: 36648268)
1. Fibrolamellar Hepatocellular Carcinoma: Comprehensive Review of Diagnosis, Imaging, and Management.
Aziz H; Brown ZJ; Panid Madani S; Kamel IR; Pawlik TM
J Am Coll Surg; 2023 Feb; 236(2):399-410. PubMed ID: 36648268
[TBL] [Abstract][Full Text] [Related]
2. Fibrolamellar carcinoma: An entity all its own.
O'Neill AF; Church AJ; Perez-Atayde AR; Shaikh R; Marcus KJ; Vakili K
Curr Probl Cancer; 2021 Aug; 45(4):100770. PubMed ID: 34272087
[TBL] [Abstract][Full Text] [Related]
3. Exploring the molecular pathogenesis, diagnosis and treatment of fibrolamellar hepatocellular carcinoma: A state of art review of the current literature.
Alshareefy Y; Shen CY; Prekash RJ
Pathol Res Pract; 2023 Aug; 248():154655. PubMed ID: 37429175
[TBL] [Abstract][Full Text] [Related]
4. [Surgical therapy of hepatic fibrolamellar carcinoma].
Meriggi F; Forni E
Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
[TBL] [Abstract][Full Text] [Related]
5. BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA.
Hirsch TZ; Negulescu A; Gupta B; Caruso S; Noblet B; Couchy G; Bayard Q; Meunier L; Morcrette G; Scoazec JY; Blanc JF; Amaddeo G; Nault JC; Bioulac-Sage P; Ziol M; Beaufrère A; Paradis V; Calderaro J; Imbeaud S; Zucman-Rossi J
J Hepatol; 2020 May; 72(5):924-936. PubMed ID: 31862487
[TBL] [Abstract][Full Text] [Related]
6. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
Bhaijee F; Locketz ML; Krige JE
S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma.
Moreno-Luna LE; Arrieta O; García-Leiva J; Martínez B; Torre A; Uribe M; León-Rodríguez E
BMC Cancer; 2005 Oct; 5():142. PubMed ID: 16259635
[TBL] [Abstract][Full Text] [Related]
8. CT and MRI of primary and metastatic fibrolamellar carcinoma: a case series of 37 patients.
Do RK; McErlean A; Ang CS; DeMatteo RP; Abou-Alfa GK
Br J Radiol; 2014 Aug; 87(1040):20140024. PubMed ID: 24896196
[TBL] [Abstract][Full Text] [Related]
9. Fibrolamellar Hepatocellular Carcinoma: A Population-Based Observational Study.
Ramai D; Ofosu A; Lai JK; Gao ZH; Adler DG
Dig Dis Sci; 2021 Jan; 66(1):308-314. PubMed ID: 32052215
[TBL] [Abstract][Full Text] [Related]
10. Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report.
Kang S; Magliocca J; Sellers M; Roccaro G; Zheng W; Pectasides M; Draper A; Guadagno J; El-Rayes B; Akce M
Oncol Res Treat; 2022; 45(7-8):430-437. PubMed ID: 35537414
[TBL] [Abstract][Full Text] [Related]
11. Fibrolamellar variant of hepatocellular carcinoma.
Chun YS; Zimmitti G
Recent Results Cancer Res; 2013; 190():101-10. PubMed ID: 22941016
[TBL] [Abstract][Full Text] [Related]
12. A framework for fibrolamellar carcinoma research and clinical trials.
Dinh TA; Utria AF; Barry KC; Ma R; Abou-Alfa GK; Gordan JD; Jaffee EM; Scott JD; Zucman-Rossi J; O'Neill AF; Furth ME; Sethupathy P
Nat Rev Gastroenterol Hepatol; 2022 May; 19(5):328-342. PubMed ID: 35190728
[TBL] [Abstract][Full Text] [Related]
13. Clinical and demographic predictors of survival for fibrolamellar carcinoma patients-A patient community, registry-based study.
Berkovitz A; Migler RD; Qureshi A; Rosemore C; Torbenson MS; Vaughan R; Marcotte E; Simon SM
Hepatol Commun; 2022 Dec; 6(12):3539-3549. PubMed ID: 36245434
[TBL] [Abstract][Full Text] [Related]
14. Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation.
McLarney JK; Rucker PT; Bender GN; Goodman ZD; Kashitani N; Ros PR
Radiographics; 1999; 19(2):453-71. PubMed ID: 10194790
[TBL] [Abstract][Full Text] [Related]
15. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
El-Serag HB; Davila JA
Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
[TBL] [Abstract][Full Text] [Related]
16. Management of fibrolamellar hepatocellular carcinoma.
Chaudhari VA; Khobragade K; Bhandare M; Shrikhande SV
Chin Clin Oncol; 2018 Oct; 7(5):51. PubMed ID: 30395718
[TBL] [Abstract][Full Text] [Related]
17. A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma.
Mavros MN; Mayo SC; Hyder O; Pawlik TM
J Am Coll Surg; 2012 Dec; 215(6):820-30. PubMed ID: 22981432
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management.
Shanbhogue AK; Prasad SR; Takahashi N; Vikram R; Sahani DV
Radiology; 2011 Mar; 258(3):673-93. PubMed ID: 21339346
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling and analysis of genetic aberrations aimed at identifying potential therapeutic targets in fibrolamellar carcinoma of the liver.
El Dika I; Bowman AS; Berger MF; Capanu M; Chou JF; Benayed R; Zehir A; Shia J; O'Reilly EM; Klimstra DS; Solit DB; Abou-Alfa GK
Cancer; 2020 Sep; 126(18):4126-4135. PubMed ID: 32663328
[TBL] [Abstract][Full Text] [Related]
20. Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas.
Wege H; Schulze K; von Felden J; Calderaro J; Reig M;
Eur J Med Genet; 2021 Nov; 64(11):104313. PubMed ID: 34418585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
